What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France
Emmanuel Cognat, François Mouton Liger, Anne-Cécile Troussière, David Wallon, Julien Dumurgier, Eloi Magnin, Emmanuelle Duron, Audrey Gabelle, Bernard Croisile, Vincent de la Sayette, Alain Jager, Frederic Blanc, Elodie Bouaziz-Amar, Carole Miguet-Alfonsi, Muriel Quillard, Susanna Schraen, Nathalie Philippi, Emilie Beaufils, Florence Pasquier, Didier Hannequin, Philippe Robert, Jacques Hugon, Claire Paquet
BMJ Open May 2019, 9 (5) e026380; DOI: 10.1136/bmjopen-2018-026380